Antiproliferative and apoptotic effects of O-Trensox, a new synthetic iron chelator, on differentiated human hepatoma cell lines
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
Biochemical Characteristics of Caspases-3, -6, -7, and -8
1997 • 536 citations
The Potential of Iron Chelators of the Pyridoxal Isonicotinoyl Hydrazone Class as Effective Antiproliferative Agents II: The Mechanism of Action of Ligands Derived From Salicylaldehyde Benzoyl Hydrazone and 2-Hydroxy-1-Naphthylaldehyde Benzoyl Hydrazone
1997 • 205 citations
Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators.
1993 • 199 citations
The Relationship of Intracellular Iron Chelation to the Inhibition and Regeneration of Human Ribonucleotide Reductase
1996 • 179 citations
The influence of zinc on apoptosis.
1995 • 176 citations
Preneoplastic significance of hepatic iron–free foci in genetic hemochromatosis: A study of 185 patients
1993 • 167 citations
Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice.
1988 • 148 citations
Cancer risk following primary hemochromatosis: A population‐based cohort study in Denmark
1995 • 140 citations
Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle.
1993 • 130 citations
Iron chelators induce apoptosis in proliferating cells
1995 • 124 citations
Iron Deprivation Inhibits Cyclin-Dependent Kinase Activity and Decreases Cyclin D/CDK4 Protein Levels in Asynchronous MDA-MB-453 Human Breast Cancer Cells
1996 • 102 citations
Effect of dietary iron deficiency or excess on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea
1991 • 79 citations
Increased risk of hepatocellular carcinoma development in patients with cirrhosis and with high hepatocellular proliferation
1994 • 66 citations
Development of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis
1992 • 63 citations
O-TRENSOX: A Promising Water-Soluble Iron Chelator (Both FeIII and FeII) Potentially Suitable for Plant Nutrition and Iron Chelation Therapy
1995 • 61 citations
Effects of iron-depletion on cell cycle progression in normal human T lymphocytes: selective inhibition of the appearance of the cyclin A- associated component of the p33cdk2 kinase
1995 • 59 citations
Direct Evidence That Iron Deprivation Induces Apoptosis in Murine Lymphoma 38C13
1997 • 53 citations
Multiple Pathways of Fas-Induced Apoptosis in Primary Culture of Hepatocytes
1996 • 45 citations
Cell cycle gene regulation in reversibly differentiated new human hepatoma cell lines.
1998 • 38 citations
Cell cycle effects of iron depletion on T-47D human breast cancer cells
1985 • 33 citations
Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine.
1990 • 31 citations
Iron Mobilisation and Cellular Protection by a New Synthetic Chelator O-Trensox
1998 • 31 citations
2,2'-Bipyridyl-6-carbothioamide and its ferrous complex: their in vitro antitumoral activity related to the inhibition of ribonucleotide reductase R2 subunit.
1993 • 26 citations
Metabolization of iron by plant cells using O-Trensox, a high-affinity abiotic iron-chelating agent
1995 • 26 citations
Deferoxamine arrests in vitro the proliferation of porcine hepatocyte in G1 phase of the cell cycle
1998 • 23 citations
Growth, ribonucleotide reductase and metals in murine leukemic lymphocytes
1991 • 15 citations
The effect of desferrioxamine on the proliferative response of rat lymphocytes stimulated with various mitogens in vitro
1984 • 10 citations